US5190955A
(en)
*
|
1987-01-28 |
1993-03-02 |
Bayer Aktiengesellschaft |
Antibacterial 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
|
JPH0674261B2
(ja)
*
|
1988-06-21 |
1994-09-21 |
塩野義製薬株式会社 |
キノロンカルボン酸誘導体
|
DD285601A5
(de)
*
|
1988-07-15 |
1990-12-19 |
Bayer Ag,De |
Verfahren zur herstellung von 7-(1-pyrrolidinyl)-3-chinolon- und naphthyridoncarbonsaeure-derivaten
|
DE3906365A1
(de)
*
|
1988-07-15 |
1990-01-18 |
Bayer Ag |
7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
|
US5140033A
(en)
*
|
1989-04-03 |
1992-08-18 |
Bayer Aktiengesellschaft |
Antibacterial 5-alkylquinolonecarboxylic acids
|
US5252734A
(en)
*
|
1989-04-03 |
1993-10-12 |
Bayer Aktiengesellschaft |
Antibacterial 5-alkylquinolonecarboxylic acids
|
ES2079391T3
(es)
*
|
1989-04-17 |
1996-01-16 |
Bayer Ag |
Procedimiento para la obtencion de 2,7-diazabiciclo(3.3.0)octanos.
|
US5241076A
(en)
*
|
1989-04-17 |
1993-08-31 |
Bayer Aktiengesellschaft |
1,4-diazatricyclo [6.3.0.0]undecanes
|
US5177210A
(en)
*
|
1989-04-17 |
1993-01-05 |
Bayer Aktiengesellschaft |
Preparation of 2,7-diazabicyclo(3.3.0)octanes
|
SE8902076D0
(sv)
*
|
1989-06-09 |
1989-06-09 |
Pharmacia Ab |
Derivatives of quinoline-3-carboxanilide
|
US5214051A
(en)
*
|
1989-08-01 |
1993-05-25 |
Pfizer Inc. |
Thiazolyl and oxazolyl[5,4-c]piperidyl-substituted quinolone-carboxylic acid and related analogs thereof having antibacterial properties are disclosed
|
US5266569A
(en)
*
|
1989-08-16 |
1993-11-30 |
Pfizer Inc. |
Azatricyclo carboxylic acids useful as anti-bacterial agents
|
KR950005301B1
(ko)
*
|
1990-09-04 |
1995-05-23 |
주식회사대웅제약 |
신규한 퀴놀론 카르복실산 유도체
|
DE4032560A1
(de)
*
|
1990-10-13 |
1992-04-16 |
Bayer Ag |
7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
|
HUT64058A
(en)
*
|
1990-12-05 |
1993-11-29 |
Synphar Lab Inc |
Process for producing 7-substituted-6-fluoro-1,4-dihydro-4-oxoquinoline-3-cqrboxylic acid compounds having antibacterial effect and pharmaceutical compositions comprising such compounds
|
US5342846A
(en)
*
|
1990-12-05 |
1994-08-30 |
Synphar Laboratories, Inc. |
7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
|
WO1992021659A1
(en)
*
|
1991-05-28 |
1992-12-10 |
Daiichi Pharmaceutical Co., Ltd. |
Pyridonecarboxylic acid derivative
|
DE4120646A1
(de)
*
|
1991-06-22 |
1992-12-24 |
Bayer Ag |
7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
|
DE4121214A1
(de)
*
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
US5468742A
(en)
*
|
1991-07-19 |
1995-11-21 |
Bayer Aktiengesellschaft |
8-vinyl- and 9-ethinyl-quinolone-carboxylic acids
|
KR950014567B1
(ko)
*
|
1991-08-01 |
1995-12-08 |
주식회사대웅제약 |
신규한 퀴놀론 카르복실산 유도체
|
EP0549857A1
(en)
*
|
1991-12-31 |
1993-07-07 |
Korea Research Institute Of Chemical Technology |
Antibacterial quinolone carboxylic acid derivatives
|
DE4200415A1
(de)
*
|
1992-01-10 |
1993-07-15 |
Bayer Ag |
Enantiomerenreine 2-oxa-5,8-diazabicyclo(4.3.0)nonane sowie verfahren zu ihrer herstellung
|
US6004956A
(en)
*
|
1992-01-10 |
1999-12-21 |
Bayer Aktiengesellschaft |
Enantiomerically pure 2-oxa-5,8-dizaabicyclo[4.3.0] nonanes and process for their preparation
|
TW209865B
(nl)
*
|
1992-01-10 |
1993-07-21 |
Bayer Ag |
|
KR960003616B1
(ko)
*
|
1992-07-23 |
1996-03-20 |
재단법인 한국화학연구소 |
우수한 항균작용을 갖는 신규한 피리돈 카르복실산 유도체 및 그의 제조방법
|
KR960003611B1
(ko)
*
|
1992-07-23 |
1996-03-20 |
재단법인 한국화학연구소 |
신규한 디아자비시클로 알켄 유도체 및 그의 제조방법
|
DE4232172A1
(de)
*
|
1992-09-25 |
1994-03-31 |
Bayer Ag |
7-(Aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)chinolon- und Naphthyridoncarbonsäure-Derivate
|
DE4234078A1
(de)
*
|
1992-10-09 |
1994-04-14 |
Bayer Ag |
Chinoloncarbonsäuren
|
DE4234330A1
(de)
*
|
1992-10-12 |
1994-04-14 |
Bayer Ag |
Chinoloncarbonsäuren
|
EG20543A
(en)
*
|
1992-10-30 |
1999-07-31 |
Procter & Gamble |
Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
|
KR940014395A
(ko)
*
|
1992-12-09 |
1994-07-18 |
강박광 |
신규한 퀴놀론 유도체 및 그의 제조방법
|
NO301165B1
(no)
*
|
1992-12-25 |
1997-09-22 |
Daiichi Seiyaku Co |
Bicykliske aminderivater og antibakterielle midler inneholdende disse
|
KR0148277B1
(ko)
*
|
1993-01-18 |
1998-11-02 |
채영복 |
신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
|
AU4272793A
(en)
*
|
1993-04-24 |
1994-11-21 |
Korea Research Institute Of Chemical Technology |
Novel quinolone carboxylic acid derivatives and process for preparing the same
|
TW252107B
(nl)
*
|
1993-08-27 |
1995-07-21 |
Hokuriku Pharmacetical Co Ltd |
|
DE4329600A1
(de)
*
|
1993-09-02 |
1995-03-09 |
Bayer Ag |
Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
|
KR950018003A
(ko)
*
|
1993-12-09 |
1995-07-22 |
스미스클라인 비참 피엘씨 |
신규한 퀴놀론 유도체 및 그의 제조 방법
|
DE4342186A1
(de)
*
|
1993-12-10 |
1995-06-14 |
Bayer Ag |
Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten
|
DE4416622A1
(de)
*
|
1994-05-11 |
1995-11-16 |
Bayer Ag |
8-Amino-10-(azabicycloalkyl)-pyrido[1,2,3-d.e] [1,3,4]benzoxa-diazinderivate
|
CN1053668C
(zh)
*
|
1994-06-14 |
2000-06-21 |
大日本制药株式会社 |
新型化合物及其制法和抗肿瘤剂
|
DE19500792A1
(de)
*
|
1995-01-13 |
1996-07-18 |
Bayer Ag |
Chinolon- und Naphthyridoncarbonsäure-Derivate
|
CN1183778A
(zh)
*
|
1995-01-24 |
1998-06-03 |
北陆制药株式会社 |
喹啉羧酸衍生物
|
US6024979A
(en)
*
|
1995-06-06 |
2000-02-15 |
Solvay Animal Health, Inc. |
Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating a microbial infection in a ruminant
|
ES2184060T3
(es)
*
|
1996-02-23 |
2003-04-01 |
Bayer Ag |
Acidos 8-cian-1-ciclopropil-7-(2,8-diazabiciclo(4,3,0)-noman -8-il)-6-fluor-1,4-dihidro-4-oxo-3-quinolincarboxilicos, en caso dado substituidos, y sus derivados.
|
US5703244A
(en)
*
|
1996-11-21 |
1997-12-30 |
Abbott Laboratories |
Process for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compounds
|
US5874554A
(en)
*
|
1996-12-13 |
1999-02-23 |
Incyte Pharmaceuticals, Inc. |
Methods and solvent vehicles for reagent delivery in oligonucleotide synthesis using automated pulse jetting devices
|
DE19652239A1
(de)
|
1996-12-16 |
1998-06-18 |
Bayer Ag |
Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
|
KR100219327B1
(ko)
*
|
1997-08-09 |
1999-09-01 |
이서봉 |
퀴놀론 카르복실산 유도체
|
EP1015445B1
(en)
|
1997-09-15 |
2009-02-25 |
The Procter & Gamble Company |
Antimicrobial quinolones, their compositions and uses
|
US6387928B1
(en)
*
|
1997-09-15 |
2002-05-14 |
The Procter & Gamble Co. |
Antimicrobial quinolones, their compositions and uses
|
SI1017392T1
(en)
*
|
1997-09-25 |
2002-12-31 |
Bayer Aktiengesellschaft |
Medicament formulation with a controlled release of an active agent
|
DE19751948A1
(de)
|
1997-11-24 |
1999-05-27 |
Bayer Ag |
Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
|
US6423843B1
(en)
|
1998-06-17 |
2002-07-23 |
Daiichi Pharmaceutical Co., Ltd. |
Enantiomerically pure substituted oxaaza compounds, salts of the same, and processes for the preparation of both
|
AR020661A1
(es)
*
|
1998-09-30 |
2002-05-22 |
Alcon Lab Inc |
Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
|
US6509327B1
(en)
|
1998-09-30 |
2003-01-21 |
Alcon Manufacturing, Ltd. |
Compositions and methods for treating otic, ophthalmic and nasal infections
|
US6716830B2
(en)
|
1998-09-30 |
2004-04-06 |
Alcon, Inc. |
Ophthalmic antibiotic compositions containing moxifloxacin
|
US6395746B1
(en)
|
1998-09-30 |
2002-05-28 |
Alcon Manufacturing, Ltd. |
Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
|
US6197974B1
(en)
|
1998-10-26 |
2001-03-06 |
Abbott Laboratories |
Enantioselective synthesis of 3-aminopyrrolidines
|
SI1128831T1
(en)
*
|
1998-11-10 |
2005-04-30 |
Bayer Healthcare Ag |
Pharmaceutical moxifloxacin preparation
|
DE19854357A1
(de)
*
|
1998-11-25 |
2000-05-31 |
Bayer Ag |
Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
|
DE19854355A1
(de)
*
|
1998-11-25 |
2000-05-31 |
Bayer Ag |
Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
|
DE19854356A1
(de)
*
|
1998-11-25 |
2000-05-31 |
Bayer Ag |
Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
|
DE19927412A1
(de)
|
1999-06-16 |
2000-12-21 |
Bayer Ag |
Verfahren zur Enantiomerenanreicherung von cis-8-Benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0]nonan
|
DE19931115A1
(de)
|
1999-07-06 |
2001-01-11 |
Bayer Ag |
Racemisierung von R, S-Dioxo-Benzylpyrrolopiperidin
|
US6552020B1
(en)
*
|
1999-07-30 |
2003-04-22 |
Allergan, Inc. |
Compositions including antibiotics and methods for using same
|
DE19937115A1
(de)
|
1999-08-06 |
2001-02-08 |
Bayer Ag |
Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
|
DE19937116A1
(de)
*
|
1999-08-06 |
2001-02-08 |
Bayer Ag |
Moxifloxacin Kochsalzformulierung
|
SE9903290D0
(sv)
*
|
1999-09-15 |
1999-09-15 |
Astra Pharma Prod |
Novel compounds
|
DE19962470A1
(de)
*
|
1999-12-22 |
2001-07-12 |
Schulz Hans Herrmann |
Verwendung von Chemotherapeutika
|
EP1262477B1
(en)
*
|
2000-02-09 |
2008-09-03 |
Daiichi Sankyo Company, Limited |
Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
|
KR20020075447A
(ko)
*
|
2000-02-25 |
2002-10-04 |
다이이찌 세이야꾸 가부시기가이샤 |
퀴놀론카복실산의 제조방법 및 이의 중간체
|
US6608078B2
(en)
|
2000-05-08 |
2003-08-19 |
Wockhardt Limited |
Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
|
DE10022369A1
(de)
*
|
2000-05-08 |
2001-11-15 |
Bayer Ag |
Verfahren zur Herstellung von Piperidinen
|
US7098219B2
(en)
|
2000-08-01 |
2006-08-29 |
Wockhart Limited |
Inhibitors of cellular efflux pumps of microbes
|
US6579904B1
(en)
|
2000-09-22 |
2003-06-17 |
K.E.R. Associates, Inc. |
Process for making betaine transition metal complexes for use in animal feed supplements and compositions thereof
|
WO2002070523A1
(en)
*
|
2001-03-07 |
2002-09-12 |
Pfizer Products Inc. |
Modulators of chemokine receptor activity
|
US20040073045A1
(en)
*
|
2001-04-06 |
2004-04-15 |
Manabu Sasyou |
Pyrrolidine derivative and process for producing the same
|
US6878713B2
(en)
*
|
2001-04-25 |
2005-04-12 |
Wockhardt Limited |
Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
|
US6964966B2
(en)
|
2001-04-25 |
2005-11-15 |
Wockhardt Limited |
Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
|
WO2003099815A1
(en)
*
|
2002-05-28 |
2003-12-04 |
Wockhardt Limited |
Crystalline fluoroquinolone arginine salt form
|
DE10226923A1
(de)
*
|
2002-06-17 |
2003-12-24 |
Bayer Ag |
Verfahren zur Enantiomerenanreicherung von cis-8-Benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonan
|
US20060252789A1
(en)
*
|
2002-10-31 |
2006-11-09 |
Sujay Biswas |
Amorphous moxifloxacin hydrochloride
|
BRPI0407368A
(pt)
|
2003-02-10 |
2006-02-14 |
Bayer Healthcare Ag |
tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.
|
JP4608922B2
(ja)
*
|
2003-06-27 |
2011-01-12 |
東レ・ファインケミカル株式会社 |
含窒素複素環化合物の製造方法
|
EP1663226A1
(en)
*
|
2003-09-03 |
2006-06-07 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of moxifloxacin and processes for their preparation
|
DE60314920T2
(de)
*
|
2003-09-04 |
2008-03-13 |
Wockhardt Ltd. |
Benzochinolizin-2-carbonsäureargininsalz- tetrahydrat
|
ITMI20032259A1
(it)
*
|
2003-11-20 |
2005-05-21 |
Chemi Spa |
Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
|
JP4573223B2
(ja)
*
|
2004-01-23 |
2010-11-04 |
東レ・ファインケミカル株式会社 |
光学活性trans−4−アミノ−1−ベンジル−3−ピロリジノールの製造方法
|
JP2005220081A
(ja)
*
|
2004-02-06 |
2005-08-18 |
Toray Fine Chemicals Co Ltd |
cis−4−アミノ−1−ベンジル−3−ピロリジノールの製造方法およびピロリジン誘導体
|
US7728031B2
(en)
|
2006-02-24 |
2010-06-01 |
Abbott Laboratories |
Octahydro-pyrrolo[3,4-b]pyrrole derivatives
|
JP4770516B2
(ja)
*
|
2006-02-28 |
2011-09-14 |
パナソニック株式会社 |
プラズマディスプレイパネル
|
SMP200800058B
(it)
*
|
2006-03-28 |
2009-09-07 |
Procter & Gamble |
Sali e polimorfi malati di un acido (3s, 5s) -7- [3-ammino-5-metilpiperidinil]-1-ciclopropil-1,4-diidro-8-metossi-4-osso-3-chinolincarbossilico
|
US7456279B2
(en)
*
|
2006-03-28 |
2008-11-25 |
The Procter & Gamble Company |
Coupling process for preparing quinolone intermediates
|
GB0612422D0
(en)
*
|
2006-06-23 |
2006-08-02 |
Generics Uk Ltd |
Novel hydrate form
|
AU2007320997B2
(en)
|
2006-11-13 |
2012-11-08 |
Cipla Limited |
Process for the synthesis of moxifloxacin hydrochloride
|
US20080139574A1
(en)
|
2006-11-30 |
2008-06-12 |
Cadila Healthcare Limited |
Novel quinoline derivatives
|
US7692015B2
(en)
*
|
2007-01-05 |
2010-04-06 |
Zheqing Wang |
Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
|
US7902227B2
(en)
*
|
2007-07-27 |
2011-03-08 |
Janssen Pharmaceutica Nv. |
C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
|
EP2188288A1
(en)
|
2007-09-11 |
2010-05-26 |
Abbott Laboratories |
Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
|
AU2008329876A1
(en)
*
|
2007-11-27 |
2009-06-04 |
Alcon Research, Ltd. |
Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
|
EP2083010A1
(en)
|
2008-01-08 |
2009-07-29 |
Chemo Ibérica, S.A. |
Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
|
CA2714580A1
(en)
*
|
2008-02-15 |
2009-08-20 |
Alcon Research, Ltd. |
Fluoroquinolone derivatives for ophthalmic applications
|
FR2928150A1
(fr)
*
|
2008-02-29 |
2009-09-04 |
Vetoquinol Sa Sa |
Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
|
DE602008001795D1
(de)
|
2008-04-30 |
2010-08-26 |
Univ Duisburg Essen |
IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel
|
EP2145891A1
(en)
*
|
2008-07-09 |
2010-01-20 |
Vetoquinol S.A. |
9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
|
EP2154137A1
(en)
|
2008-08-04 |
2010-02-17 |
Chemo Ibérica, S.A. |
Crystalline form of moxifloxacin base
|
CN101429199B
(zh)
*
|
2008-09-08 |
2010-12-15 |
华东师范大学 |
外消旋顺式8-苄基-7,9-二氧代-2,8-二氮杂双环[4.3.0]壬烷的制备方法
|
JP5461565B2
(ja)
|
2008-10-09 |
2014-04-02 |
アブディ イブラヒム イラク サナイ ベ ティカレット アノニム シルケティ |
有機溶媒を使用したモキシフロキサシンの湿式造粒法
|
WO2010066385A1
(de)
|
2008-12-08 |
2010-06-17 |
Ratiopharm Gmbh |
Kompaktiertes moxifloxacin
|
WO2010093341A1
(en)
*
|
2009-02-10 |
2010-08-19 |
Janssen Pharmaceutica N.V. |
C-7 isoxazolinyl quinolone/naphthyridine derivatives useful as antibacterial agents
|
IT1393337B1
(it)
|
2009-03-06 |
2012-04-20 |
Italiana Sint Spa |
Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
|
EP2423211B1
(en)
*
|
2009-04-20 |
2014-04-16 |
Kaneka Corporation |
Processes for producing (1s,6s)- or (1r,6r)-cis-2,8-diazabicyclo[4.3.0]nonane and intermediate thereof
|
WO2010131054A1
(en)
|
2009-05-15 |
2010-11-18 |
Bradford Pharma Limited |
Redox drug derivatives
|
CN102675308A
(zh)
*
|
2011-03-17 |
2012-09-19 |
苏州中科天马肽工程中心有限公司 |
一种制备8-苄基-2,8-二氮杂二环[4.3.0]壬烷的方法
|
CN105130967B
(zh)
*
|
2011-05-13 |
2018-04-17 |
阵列生物制药公司 |
作为trka激酶抑制剂的吡咯烷基脲和吡咯烷基硫脲化合物
|
CN102964346B
(zh)
*
|
2011-09-01 |
2015-04-22 |
中国中化股份有限公司 |
一种制备(S,S)-八氢-6H-吡咯并[3,4-b]吡啶的方法
|
CN103874514B
(zh)
|
2011-10-12 |
2017-04-12 |
优瑟夫·雅阿科比 |
隐形眼镜清洁系统
|
CN102399219A
(zh)
*
|
2011-11-18 |
2012-04-04 |
太仓市运通化工厂 |
一种盐酸莫西沙星中间体的制备方法
|
BRPI1106900A2
(pt)
|
2011-12-26 |
2013-11-05 |
Ems Sa |
Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
|
WO2014087292A1
(en)
|
2012-12-04 |
2014-06-12 |
Mankind Research Centre |
An improved process for the preparation of moxifloxacin hydrochloride
|
CN105143219A
(zh)
|
2012-12-21 |
2015-12-09 |
曼康德研究中心 |
用于制备作为氮杂双环吡啶衍生物的中间体的(s,s)-6-苄基八氢-1h-吡咯并[3,4-b]吡啶的方法
|
JP6056036B2
(ja)
|
2013-01-31 |
2017-01-11 |
高砂香料工業株式会社 |
光学活性2−アリールピペリジニウム塩の製造方法
|
RU2561037C2
(ru)
*
|
2013-02-07 |
2015-08-20 |
Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") |
Антибактериальная фармацевтическая композиция и способ ее получения
|
GR1008168B
(el)
|
2013-03-14 |
2014-04-08 |
"Φαρματεν Α.Β.Ε.Ε.", |
Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
|
MX2015011760A
(es)
|
2013-03-15 |
2016-06-10 |
Melinta Therapeutics Inc |
Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.
|
MX2016001912A
(es)
|
2013-08-12 |
2016-06-02 |
Novartis Ag |
Metodos para tratar infecciones oticas luego de la colocacion de un tubo de timpanostomia.
|
GB201322334D0
(en)
*
|
2013-12-17 |
2014-01-29 |
Agency Science Tech & Res |
Maleimide derivatives as modulators of WNT pathway
|
RU2558932C1
(ru)
*
|
2014-05-22 |
2015-08-10 |
Открытое Акционерное Общество "Татхимфармпрепараты" |
Фармацевтическая композиция моксифлоксацина и способ ее приготовления
|
EP2957561A1
(en)
|
2014-06-18 |
2015-12-23 |
Université Paris 6 Pierre et Marie Curie UPMC |
Novel fluoroquinolones and use thereof to treat bacterial infections
|
CR20170566A
(es)
|
2015-06-09 |
2018-03-20 |
Bayer Pharma AG |
Moduladores alostéricos positivos del receptor muscarínico m2
|
US10130639B1
(en)
|
2015-09-05 |
2018-11-20 |
Randal Davis |
Homogeneous ophthalmic composition
|
US11452732B2
(en)
|
2015-09-05 |
2022-09-27 |
Randal Davis |
Homogeneous ophthalmic composition
|
US10519154B2
(en)
|
2016-07-11 |
2019-12-31 |
Bayer Pharma Aktiengesellschaft |
7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof
|
CN107602465A
(zh)
*
|
2016-07-12 |
2018-01-19 |
重庆大学 |
一种喹诺酮类衍生物及其应用
|
JOP20190045A1
(ar)
*
|
2016-09-14 |
2019-03-14 |
Bayer Ag |
مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
|
EP3296298A1
(de)
*
|
2016-09-14 |
2018-03-21 |
Bayer Pharma Aktiengesellschaft |
7-substituierte 1-aryl-naphthyridin-3-carbonsäureamide und ihre verwendung
|
PT3512849T
(pt)
*
|
2016-12-06 |
2021-09-08 |
Bayer Pharma AG |
1-arilnaftiridina-3-carboxamidas 7-substituídas e sua utilização
|
CN113527288A
(zh)
*
|
2020-04-16 |
2021-10-22 |
沈阳药科大学 |
喹诺酮羧酸衍生物或二氮杂萘酮羧酸衍生物的制备方法
|
WO2021257461A1
(en)
*
|
2020-06-15 |
2021-12-23 |
Mylan Laboratories Limited |
Combination antibacterial composition and method for antibacterial therapy
|